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Abstract
Biogenic amines are low molecular weight organic nitrogen compounds. They 
are formed by the decarboxylation of amino acids or by amination and transamina-
tion of aldehydes and ketones during normal metabolic processes in living cells and 
therefore are ubiquitous in animals, plants, microorganisms, and humans. In food 
and beverages, they are formed by the enzymes of raw materials or are generated by 
microbial decarboxylation of amino acids. The structure of a biogenic amine can be 
aromatic and heterocyclic amines (histamine, tryptamine, tyramine, phenylethyl-
amine, and serotonin); aliphatic di-, tri-, and polyamines (putrescine, cadaverine, 
spermine, spermidine, and agmatine); and aliphatic volatile amines (ethylamine, 
methylamine, isopentylamine, and ethanolamine). Many of them possess a strong 
pharmacologic effect, and others are important as precursors of hormones and com-
ponents of coenzymes. The biogenic amine intoxication leads to toxicological risks 
and health hazards that trigger psychoactive, vasoactive, and hypertensive effects 
resulting from consumption of high amounts of biogenic amines in foods. The 
toxicological effects of biogenic amines increase when the mono- and diaminoxidase 
enzymes are deficient or drugs that inhibit these enzymes (pain reliever, stress, and 
depression drugs) are used. In this chapter, biosynthesis of biogenic amines, their 
toxic effects as well as their physiological functions, and their effect on health will be 
described.
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1. Introduction
Biogenic amines found in animals, plants, microorganisms, and humans are 
formed by the decarboxylation of amino acids or amination and transamination of 
aldehydes and ketones during the standard metabolic processes.
Biogenic amines, having several critical biological roles in the body, have 
essential physiological functions such as the regulation of growth and blood 
pressure and control of the nerve conduction. Besides, they are required in the 
immunologic system of intestines and in maintaining the activity of the standard 
metabolic functions, and when taking the nourishment in high concentrations, 
they cause disorders in nervous, respiratory, and cardiovascular systems and 
allergic reactions as well. In this chapter, biosynthesis of biogenic amines, their 
toxic effects as well as their physiological functions, and their effect on health will 
be presented.
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2. Biogenic amines
2.1 Decarboxylation of amino acids
CO2 and biogenic amine occur as a result of the enzymatic reaction catalyzed 
by pyridoxal phosphate to decarboxylate the amino acid (Figure 1) [1]. Biogenic 
amines are biologically active molecules, as they are formed by decarboxylation 
of amino acids or amination and transamination of aldehydes and ketones during 
standard metabolic processes [2]. Biogenic amines take charge of the proliferation 
and differentiation of cells and their metabolism by entering into the structure of 
hormones, cobalamin (vitamin and aminoacetone), and coenzyme A in the body 
[3]. They have importance regarding the environment by causing water pollution, 
as their formations pertain to the amino acid and microorganisms [3, 4]. Biogenic 
amines may cause intoxications when taken in high amounts [5].
2.2 Classification of the biogenic amines
Biogenic amines are organic nitrogen compounds having a low molecular weight 
[5, 6]. Their chemical structure can be classified as (i) aromatic and heterocyclic 
(histamine, tryptamine, tyramine, phenylethylamine, and serotonin); (ii) aliphatic 
di-, tri-, and polyamines (putrescine, cadaverine, spermine, spermidine, and agma-
tine); and (iii) aliphatic volatile amines (ethylamine, methylamine, isopentylamine, 
and ethanolamine) (Figure 2) [7, 8]. Besides, their amine group classifications 
include (i) monoamine (phenylethylamine, tyramine, methylamine, ethylamine, 
isopentylamine, and ethanolamine), (ii) diamine (histamine, tryptamine, sero-
tonin, putrescine, and cadaverine), and (iii) polyamine (spermine, spermidine, and 
agmatine) [7–9].
2.3 Biosynthesis and functions
Biogenic amines generally occur as a result of free amino acid decarboxylations 
with the microbial enzymes. Amino acid decarboxylation happens by removal of 
the α-carboxyl group [10]. Their occurrences are as below: histamine from histidine 
amino acid, tyramine from tyrosine amino acid, tryptamine and serotonin from 
tryptophan amino acid, phenylethylamine from phenylalanine amino acid, putres-
cine from ornithine amino acid, cadaverine from lysine amino acid, and agmatine 
from arginine amino acid (Figure 3) [11–13].
Biogenic amines play an essential role in cell membrane stabilization, immune 
functions, and prevention of chronic diseases, as they participate in the nucleic acid 
and protein synthesis [14]. Besides, they are compounds created as the growth regu-
lation (spermine, spermidine, and cadaverine), neural transmission (serotonin), 
and inflammation mediators (histamine and tyramine) [6, 15].
Histamine, a standard component of the body, consists of histidine amino acid 
as a result of histidine decarboxylase activity depending on pyridoxal phosphate 
Figure 1. 
Decarboxylation of amino acids.
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(Figure 3) [16]. Histamine distribution and concentration found in the tissues of 
all vertebrates are very unsteady [17, 18]. Histamine takes charge of some functions 
related to balancing the body temperature and regulating the stomach volume, 
stomach pH, and cerebral activities [19] as it participates in the essential functions 
such as neurotransmission and vascular permeability [20, 21]. However, it also plays 
a role in starting the allergic reactions [22, 23].
Tryptamine consists of tryptophan amino acid as a result of the aromatic 
L-amino acid decarboxylase activity (Figure 3) [24, 25]. Tryptamine is a mono-
amine alkaloid found in plants, fungi, and animals [26]. Tryptamine, found in trace 
amounts in mammalian brains, increases blood pressure [10, 27] as well as plays a 
role as a neurotransmitter or neuromodulator [26].
The amino acid of phenylalanine synthesizes phenylethylamine through the 
aromatic L-amino acid decarboxylase in humans, some fungi, and bacteria as well 
as several plants and animal species (Figure 3) [28–30]. It functions as a neu-
rotransmitter in the human central nervous system [31, 32].
Figure 2. 
Classification of biogenic amines according to their chemical structures.
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Tyramine, consisting of tyrosine amino acid as a result of tyrosine decarboxylase 
activity, is generally found in low amounts (Figure 3) [33–36]. Tyramine leads to 
several physiological reactions such as blood pressure increase, vasoconstriction 
[37], tyramine active noradrenalin secretion, etc., as the sympathetic nervous system 
controls several functions of the body [38, 39]. Tyramine, stored in the neurons, 
causes the increase in the tear, salivation and respiratory as well as mydriasis [39].
Tryptophan synthesizes serotonin as a result of tryptophan hydroxylase and aro-
matic L-amino acid decarboxylase enzyme activities (Figure 3) [11, 40]. Serotonin, 
one of the crucial neurotransmitters of the central nervous system, plays a role in 
plenty of critical physiological mechanisms such as sleep, mood disorders, appetite 
regulation, sexual behavior, cerebral blood flow regulation, and blood-brain barrier 
permeability [41, 42].
Putrescine consists of ornithine amino acid as a result of ornithine decarboxyl-
ase activity. Besides, it may be synthesized by arginine through the agmatine and 
carbamoylputrescine (Figure 3) [12, 39, 43, 44]. Putrescine, produced by bacteria 
and fungi, contributes to the cell growth, cell division, and tumorigenesis [45, 46] 
as it is the preliminary substance of spermidine and spermine [12, 47].
Cadaverine, synthesized by lysine as a result of lysine decarboxylase enzyme activ-
ity, takes charge of the diamine and polyamine formations (Figure 3) [45, 48, 49].
Spermidine synthase catalyzes spermidine formation from putrescine (Figure 3) 
[50, 51]. Spermidine is a precursor of other polyamines such as spermine and structural 
isomer thermospermine [45, 52]. Spermidine, regulating several crucial biological 
processes (Na+-K+ ATPaz), protects the membrane potential and controls the intra-
cellular pH and volume [53]. Besides, spermidine, a polyamine found in the cellular 
Figure 3. 
Formation mechanism of biogenic amines.
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metabolism, has a role in the neuronal nitric oxide synthase inhibitions and intestinal 
tissue developments [54].
Spermine, whose precursor amino acid is ornithine, is formed from spermidine 
through the spermine synthase enzyme (Figure 3) [51]. Spermine is present in 
several organisms and tissues, as it is a polyamine that is found in all eukaryotic 
cells and has a role in the cellular metabolism [52, 55]. It plays a role in the intestinal 
tissue developments and stabilizes the helical structure in viruses [52, 56, 57].
Agmatine is a biogenic amine formed by arginine decarboxylase enzyme activ-
ity of arginine amino acid (Figure 3) [12, 44, 58]. Agmatine participates in the 
polyamine metabolism over the putrescine hydrolyzed by the agmatine enzyme 
and has several functions such as nitric oxide synthesis regulation, polyamine 
metabolism, and matrix metalloproteinase and enzyme activity leading to H2O2 
production [59, 60].
The detoxification system, splitting the biogenic amines in the human body, 
consists of monoamine oxidase (MAO), diamine oxidase (DAO), polyamine oxidase 
(PAO), and histamine-N-methyl transferase (HNMT) [17, 61, 62].
3. Effect of biogenic amines on health
Biogenic amines have several important biological roles in the body and 
constitute the first step of protein, hormone, and nucleic acid synthesis [61, 63].  
The polyamines such as putrescine, spermine, and spermidine are the unique 
components of living cells. Besides, the polyamines were stated to require maintain-
ing the intestinal immunologic systems and healthy metabolic function activities 
[52, 64–67]. The biogenic amines cause respiratory disorders, headache, tachycardia, 
hypo- or hypertension, and allergic reactions when taken in high concentrations 
together with nutrients [68].
Biogenic amines are vasoactive components, and taking them in high amounts 
leads to change in blood pressure in humans and animals. The amines bear essen-
tial psychoactive or vasoactive effects, as they have the biological activities such as 
histamine, tryptamine, tyramine, and phenylethylamine [33]. Histamine is a bio-
logically active amine and quickly scatters to the tissues through blood circulation 
and leads to several reactions. However, in the case where aminoxidase enzyme 
inhibitors are present in the environment, the biogenic amine prevents detoxifica-
tion, and health problems (erythema, edema, rash, headache, burning, etc.) show 
up [17, 68]. Histamine also has essential metabolic functions such as a role in the 
nervous system functions and blood pressure control. It mainly takes effect by 
binding to the cardiovascular system (vasodilatation and hypotension) and cell 
membrane receptors in several secretory glands (such as gastric acid secretion) 
[22, 23]. In addition to them, it may lead to some neurotransmission disorders and 
causes headache, flushing, gastrointestinal disorders, and edema by giving rise 
to blood vessel dilatations [61, 69]. Histamine intoxicates when orally taken in 
amounts of 8 mg and above [3]. Individuals generally have lower intestinal oxidase 
enzyme activities according to the healthy persons, as they hold the gastrointesti-
nal problems such as gastritis, stomach and colonic ulcers [6, 69].
Intestinal mucosal injuries may decrease the enzyme functions by detoxifying 
the biogenic amines [17, 63]. The DAO activity disruption causes histamine intoler-
ance and also allergic reactions as a result of the drug utilization, as it is caused by 
genetic and gastrointestinal diseases or DAO inhibition [17, 70]. It was found to 
increase the histamine toxicity by preventing the histamine oxidation of putrescine, 
cadaverine, and agmatine in humans [71].
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Biogenic amines lead to hypertension, as they have vasoconstriction effects such 
as tyramine, phenylethylamine, and tryptamine [37, 68, 72]. Consuming tyramine-
rich nutriments was found to react with the tyramine MAO inhibitor drugs and 
cause hypertensive crisis and also migraine in some patients [73]. Tyramine is 
revealed to inhibit MAO, tryptamine DAO, phenylethylamine DAO, and HNMT 
enzymes [74, 75].
In the case of deficiency of putrescine, found in the high concentration in brains, 
is stated to develop the depression and also useful in the depression physiopathol-
ogy [3, 76].
The pharmacological effects of putrescine, cadaverine, spermine, and spermi-
dine are at lower levels according to histamine, tyramine, and phenylethylamine 
[77]. Putrescine, causing hypotension, bradycardia, and lockjaw, creates carci-
nogenic heterocyclic compounds including nitrosamine, nitrosopyrrolidine, and 
nitrosopiperidine as some biogenic amines such as cadaverine, spermine, and 
spermidine react with the nitrite [5, 10, 39, 78].
Polyamines are known to lead to low-dose colon cancer by affecting the cell 
developments and differentiation [79, 80]. In addition to them, putrescine, cadaver-
ine, spermine, and spermidine were also found to induce apoptosis and inhibit cell 
proliferation. The high-dose putrescine was found to induce apoptosis and prevent 
the spread [81, 82]. This putrescine effect pertains to increasing the nitric oxide 
synthesis, inhibiting the redox reactions and binding directly to the carcinogenic 
agents [82].
Eating disorders such as anorexia nervosa and bulimia nervosa disrupt the 
function of brain serotonin [83]. Albumin deficiency shows up due to inadequate 
nutrition, and tryptophan transition from the blood-brain barrier increases, as it 
could not connect to the albumin. As a consequence, an increase occurs in the brain 
serotonin concentration [84, 85]. The drugs (MAO inhibitors) are used, as they 
change the serotonin levels in the depression, generalized anxiety disorder, and 
social phobia treatments [86]. The MAO inhibitors, used in treating these diseases, 
increase the brain concentrations by preventing the neurotransmitter (serotonin) 
disruptions [73, 86].
Agmatine shows a nephroprotective effect by increasing the glomerular filtra-
tion rate, and it also has a hypoglycemic impact as a result of several molecular 
mechanisms taking place in the blood glucose regulation [56, 87]. Besides, the 
agmatine level of schizophrenia patients was shown to be higher compared to that 
of healthy humans [88].
4. Conclusion
The present information related to biogenic amines having different physiological 
functions and similar chemical structures and metabolic pathways was updated, 
undesirable effects were considered more comprehensively for human and animal 
health, and information was submitted about the essential diseases caused by bio-
genic amines.
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